NZ-designed drug shows exciting early promise against lung cancer
November 24th, 2009
New Zealand scientists have discovered a new class of drugs that could become the next big thing in the treatment of lung cancer.
Medicinal chemist Dr Jeffrey Smaill and cancer biologist Dr Adam Patterson, investigators with the Maurice Wilkins Centre for Molecular Biodiscovery, have just arrived back in New Zealand from the world’s premier conference for molecular targets and cancer therapeutics in Boston, US, where they announced the discovery of a new class of anti-cancer drugs.